Literature DB >> 31656427

Radical cystoprostatectomy to treat urachal carcinoma.

Ahmed Ebrahim1, Nitin Kondapalli2, W Scott Webster3.   

Abstract

Urachal carcinoma is a highly uncommon malignancy with an estimated prevalence of 0.01% to 0.02% of all adult cancers. Due to its rarity, no standardized management protocol for urachal cancer has been developed. Surgery is often the main therapeutic measure. A 48-year-old man presented with hematuria for 8 months. Imaging revealed a mass at the bladder dome. Biopsy indicated mixed adenocarcinoma with a small cell component. Radical cystoprostatectomy with ileal urostomy was performed. After surgical resection, he was diagnosed with urachal adenocarcinoma (mixed type). The patient tolerated surgery and was discharged home uneventfully. Follow-up computed tomography at 6 months was negative.
Copyright © 2019 Baylor University Medical Center.

Entities:  

Keywords:  Cystoprostatectomy urachal; urachal carcinoma; urachus cancer

Year:  2019        PMID: 31656427      PMCID: PMC6793955          DOI: 10.1080/08998280.2019.1646592

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  The clinical epidemiology of urachal carcinoma: results of a large, population based study.

Authors:  H Max Bruins; Otto Visser; Martine Ploeg; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; J Alfred Witjes
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

2.  Urachal anomalies in children: a single center experience.

Authors:  Youn Joung Choi; Jong Min Kim; Sun Young Ahn; Jung-Tak Oh; Sang Won Han; Jae Seung Lee
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

Review 3.  Malignant urachal lesions.

Authors:  C A Sheldon; R V Clayman; R Gonzalez; R D Williams; E E Fraley
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

Review 4.  Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.

Authors:  Tibor Szarvas; Orsolya Módos; Christian Niedworok; Henning Reis; Attila Szendröi; Marcell A Szász; Péter Nyirády
Journal:  Urol Oncol       Date:  2016-06-03       Impact factor: 3.498

Review 5.  [Two Cases of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].

Authors:  Michinobu Ozawa; Akito Kuromoto; Kento Morozumi; Masahiko Satou; Senji Hoshi; Kenji Numahata
Journal:  Hinyokika Kiyo       Date:  2017-10

Review 6.  Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.

Authors:  Gladell P Paner; Antonio Lopez-Beltran; Deepika Sirohi; Mahul B Amin
Journal:  Adv Anat Pathol       Date:  2016-03       Impact factor: 3.875

Review 7.  Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.

Authors:  Mark A Behrendt; Jeroen DE Jong; Bas W VAN Rhijn
Journal:  Minerva Urol Nefrol       Date:  2015-11-18       Impact factor: 3.720

8.  National Incidence, Management and Survival of Urachal Carcinoma.

Authors:  Dearbhaile C Collins; Kyra Velázquez-Kennedy; Sandra Deady; Adrian P Brady; Paul Sweeney; Derek G Power
Journal:  Rare Tumors       Date:  2016-10-05

9.  Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence.

Authors:  Masato Yasui; Ryosuke Jikuya; Tomoyuki Tatenuma; Kentaro Muraoka; Susumu Umemoto; Masaki Kawai; Tsutomu Kouno; Takeshi Kishida
Journal:  Case Rep Urol       Date:  2018-06-13
  9 in total
  1 in total

1.  Clinical and Radiological Features of Urachal Carcinoma and Infection.

Authors:  Shichao Li; Xiaoyan Meng; Ping Liang; Cui Feng; Yaqi Shen; Daoyu Hu; Zhen Li
Journal:  Front Oncol       Date:  2021-09-07       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.